Accumetrics Press Releases

Accumetrics, Inc., Daiichi Sankyo, Inc. and Eli Lilly and Company Launch Strategic U.S. Collaboration
July 12, 2010, San Diego, CA, Parsippany, NJ and Indianapolis, IN -- Accumetrics, Inc., Daiichi Sankyo, Inc, and Eli Lilly and Company announced today that the companies have entered into a strategic collaboration in the United States to raise awareness about antiplatelet therapy and the role of platelet function testing. Click here for more information.

Accumetrics Forges New Partnership with Medico’s Hirata for VerifyNow® System in Japan
May 18, 2010 San Diego, CA, -- Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed a new agreement with Medico’s Hirata for distribution of its VerifyNow System in Japan. Click here for more information.

Accumetrics, Inc. Announces Completion of GRAVITAS Trial Enrollment
April 6, 2010, San Diego, Calif. -- Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow® System, the first rapid and easy to use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced that it has completed the enrollment phase of its landmark clinical trial, GRAVITAS (Gauging Responsiveness with A VerifyNow® Assay Impact on Thrombosis And Safety). Click here for more information.

Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCI
March 15, 2010, San Diego, CA, -- Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced the presentation of a 2,000 patient meta-analysis examining patient response to antiplatelet therapy after percutaneous coronary intervention (PCI). Data from the patient-level meta-analysis show that individuals with an inadequate response to clopidogrel have a higher incidence of major adverse cardiac events. Click here for more information.

Accumetrics To Host Industry-Expert Theater Presentation at 59th Annual American College of Cardiology 2010 Scientific Sessions
March 8, 2010 San Diego, CA, -- Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow® System, the first rapid and easy-to-use diagnostic system for measuring platelet reactivity to multiple antiplatelet agents (e.g. Plavix® and aspirin), announced today that the company will host an industry–expert theater presentation on Monday, March 15, during the 59th annual American College of Cardiology Meeting. Click here for more information.

Accumetrics Achieves ISO 13485 Medical Device Certification
January 7, 2010, San Diego, Calif. – Accumetrics, Inc., developer and marketer of the VerifyNow® System, the first rapid and easy-to-use diagnostic system for measuring an individual’s response to multiple antiplatelet agents, announced today that the Company has received a certificate of registration to ISO 13485: 2003, the Quality Management System, a standard developed by the International Organization for Standardization for medical device manufacturers. Click here for more information.

Accumetrics Closes 2009 with Positive Outlook
December 15, 2009, San Diego, Calif. – Accumetrics, Inc., developer and marketer of the VerifyNow® System, the first rapid and easy-to-use diagnostic system for measuring an individual’s response to multiple antiplatelet agents, announced that 2009 included a doubling in the number of international and U.S. distribution agreements, as well as positive medical community support, and significant capital financing that will take the company into 2011. Click here for more information.

Accumetrics To Present At The 21st Annual Piper Jaffray Health Care Conference
November 24th, 2009, San Diego, CA , -- Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow® System, the first rapid and easy-to-use diagnostic system for measuring an individual’s response to multiple antiplatelet agents (e.g. Plavix® and aspirin), announced today that Timothy I. Still, President and CEO of Accumetrics, and Gregory J. Tibbitts, Chief Financial Officer of Accumetrics, will be presenting a corporate overview at the 21st Annual Piper Jaffray Health Care Conference being held in New York City on December 1-2, 2009 at The Palace Hotel. Click here for more information.

VerifyNow System Highlighted in POPular Study Comparing Platelet Reactivity Tests
November 19, 2009, San Diego, CA -- Accumetrics, Inc., developer of the VerifyNow System, the first point-of-care method for measuring platelet reactivity, announces that its market-leading VerifyNow P2Y12 Test was one of multiple methods evaluated in the POPular study, which was presented during a Late Breaking Clinical Trials session at the American Heart Association’s annual Scientific Sessions. Click here for more information.

Accumetrics Announces $16.5M In New Capital Financing
Despite Difficult Markets, Cutting-Edge Medical Diagnostics Company Oversubscribes Its Fundraising Effort Click here for more information.

Accumetrics, Inc. Announces Endotech SPA as Exclusive Distributor for the VerifyNow; System in Italy
September 15 2009, San Diego, Calif. – Accumetrics, Inc. announces today it has signed a new exclusive agreement with Endotech SPA for distribution of its VerifyNow® System in Italy. With the addition of Endotech to Accumetrics’ growing number of distribution partners, Accumetrics now has local representation in 25 countries in Europe, Latin America and Asia / Pacific. Click here for more information.

Accumetrics, Inc. Forms Partnership with Grifols as Its Distributor in Spain, Portugal and Chile
September 2, 2009, San Diego, Calif. – Accumetrics, Inc. has announced the signing of a new exclusive distribution agreement for its VerifyNow® System in Spain, Portugal and Chile with Grifols S.A.. This distribution agreement will continue to expand Accumetrics’ reach in both scope and geography, and add to the growing numbers of countries where physicians have access to the VerifyNow System. Click here for more information.

Accumetrics’ Verify Now P2Y12 Test Provides Physicians with Information to Assess a Patient’s Response to Newly-Approved Prasugrel (Effient)
July 14, 2009, San Diego, Calif. – With the recent FDA approval of the new P2Y12 inhibitor, prasugrel (Effient), Accumetrics, Inc. announces that its VerifyNow P2Y12 Test is not only able to assess response to Plavix®, but also its newly approved competitor, Effient. Click here for more information.

Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
June 30, 2009, San Diego, Calif. -- Accumetrics, Inc. announces that it has reached the halfway mark (1,600 patients) in the enrollment of its landmark clinical trial, GRAVITAS (Gauging Responsiveness with A VerifyNow® Assay Impact on Thrombosis And Safety). Click here for more information.

Accumetrics, Inc. Announces Distribution Channels in Israel and Cyprus
June 9, 2009, San Diego, Calif. – Accumetrics, Inc. announces today it has signed new distribution agreements for its VerifyNow® System in both Israel and Cyprus. Click here for more information.

Accumetrics, Inc. Announces European Distribution Channels
Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg Click here for more information.

Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial
May 13 2009, San Diego, Calif. -- Accumetrics, Inc. announces that it has enrolled its 1,000th patient into its landmark clinical trial, GRAVITAS (Gauging Responsiveness with A VerifyNow® Assay Impact on Thrombosis And Safety). Click here for more information.

Accumetrics, Inc. Announces United Kingdom Distribution Agreement with ELITech UK Limited
April 23, 2009, San Diego, Calif. – Accumetrics, Inc. announces today an exclusive distribution agreement with ELITech UK Limited for distribution of the VerifyNow System in the United Kingdom. Click here for more information.

Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
February 26, 2009, San Diego, Calif. -- Accumetrics, Inc. announced today that the Company has appointed Gregory J. Tibbitts, CPA to the position of Chief Financial Officer. Click here for more information.

Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics
January 6, 2009, San Diego, Calif. -- Accumetrics, Inc. has appointed Andrew Chisholm to the position of Vice President, Sales and Corporate Accounts. Click here for more information.

Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
December 16, 2008, San Diego, Calif. -- Accumetrics, Inc. has appointed 20-year industry veteran Ad de Waard as Vice President of International Sales and Marketing. Click here for more information.

Accumetrics Appoints John J. Young, MD Chief Medical Officer
November 11, 2008, San Diego, Calif. -- Accumetrics, Inc. has announced the appointment of John J. Young, MD as Chief Medical Officer for the company. Click here for more information.

Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
SAN DIEGO, CA, Nov. 04, 2008 - Accumetrics, Inc. announces the appointment of William H. Dippel to the position of Executive Vice President of Operations and R&D. Mr. Dippel will oversee the Operations, Research and Product Development departments at Accumetrics. Click here for more information.

Timothy I. Still Appointed CEO at Accumetrics
October 29th, 2008, San Diego, Calif. -- Accumetrics, Inc. has appointed Timothy I. Still to the additional position of Chief Executive Officer. Mr. Still has been serving in the capacity of President and Chief Operating Officer for the company since earlier this year. Click here for more information.

Anthony Arnerich appointed Executive Chairman at Accumetrics
September 25th, 2008, San Diego, Calif. -- Accumetrics, Inc. has announced the appointment of Anthony Arnerich as Executive Chairman of the Board of Directors. Arnerich replaces Dr. Robert Hillman, who will continue to serve on the Board of Directors for the company. Accumetrics has also announced that Steven Frankel will be leaving the position as CEO of the company. Click here for more information.